pharmaphorum

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from ...
pharmaphorum

J&J plots filings after psoriasis drug clears phase 3 test

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
C&EN

Calibration-Free, Seconds-Resolved In Vivo Molecular Measurements using Fourier-Transform Impedance Spectroscopy Interrogation of Electrochemical Aptamer Sensors

Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States Center for Bioengineering, University of California Santa Barbara, ...